We aim to develop Cytiva’s innovation pipeline by working and partnering with the best external organisations and innovators available to us.
Partnering with external organisations enables Cytiva to access and develop technologies which in turn allows us to support our customers to discover, diagnose and manufacture new medicines.
We recognise the wealth of innovation available within the external scientific community and continue to actively seek value-enhancing opportunities across our areas of interest.
We also have a broad patent portfolio available for licensing that spans many different technologies, reagents and, methods. Please see our out-licensing page for more information.
We base our partnering relationships on an open, flexible and collaborative environment where knowledge and resources are shared. Some of the advantages to working with Cytiva include:
- Cytiva's deep understanding of the hurdles associated with commercialising intellectual property at all stages of development – we can bridge the translational gap from idea to commercial product
- Cytiva's commercial presence in over 100 countries and R&D sites throughout the world – partners can benefit from our local market knowledge and global resources
- Tailor made alliance arrangements – we understand that no alliance is the same and consider each parties’ motivation and goals when formulating an appropriate agreement
We have many long-term relationships with both industrial and academic partners and support a wide range of alliance types in our areas of interest including:
- Technology Evaluations
- Research Collaborations
- Patent and Product In-licensing
- Product Acquisitions
We are flexible in our approach and work with new potential partners to reach an agreement that combines our strengths.
Do you have a novel idea or do you know of a technology or product that you believe would be of interest to Cytiva?
Are you interested in one of our patented technologies or would you like to understand how our manufacturing experience can benefit you?
If yes, please feel free to connect with us. Please note that all initial submissions should be non-confidential.